Aim To investigate clinical and obstetrical characteristics, an outcome and a prognosis for pregnant women with diagnosed and treated genital or extragenital cancer and their newborns. Methods This retrospective cohort study included pregnant and childbearing women with a history of cancer diagnosed before pregnancy during the period between 1 January 2014 and 31 December 2018. Data related to the course of pregnancy and childbirth were collected from medical records (mothers' disease history and partogram). The analysis covered clinical and histopathological characteristics of cancers, type of the treatment (surgery, chemotherapy, radiotherapy), demographic data, obstetric characteristics, comorbidities of women, and outcome of the newborns. Results The study recorded 18 414 deliveries, of which 30 (0.16%) were pregnancies in women who had been diagnosed and treated earlier for genital or extragenital cancer. The average age of the women at the time of delivery was 29.43±5.97 years. There were six (20%) women with genital and 24 (80%) with extragenital cancer. The most frequent extra genital cancer was Hodgkin lymphoma, in eight (26.6%) cases; ovarian cancer was the most frequent genital cancer, in four (13.3%) cases. The average time span from the cancer diagnosis and start of the treatment to the delivery was 59.2±44.4 months (5 years) (range 12 months-15 years). Two (6.6%) women died. Conclusion Our data demonstrate a favourable obstetric and neonatal outcome for women who have survived cancer.
Davutoğlu A, Madazlı E, Yılmaz R, Ozel N, Uludag A, Sozen S, et al. Pregnancy in cancer patients and survivors; experience of a university hospital in Turkey. J Obstet Gynaecol. 2017. p. 1015–9.
2.
Clark H, Kurinczuk J, Lee A, Bhattacharya S. Obstetric outcomes in cancer survivors. Obstet Gynecol. 2007. p. 849–54.
3.
Landa A, Kuller J, Rhee E. Perinatal considerations in women with previous diagnosis of cancer. Obstet Gynecol Surv. 2015. p. 765–72.
4.
Jeremic K, Stefanovic A, Dotlic J, Kadija S, Kontic O, Gojnic M, et al. Cancer during pregnancy -clinical characteristics, treatment outcomes and prognosis for mothers and infants. J Perinat Med. 2018. p. 35–45.
5.
Stensheim H, Cvancarova M, Møller B, Fosså S. Pregnancy after adolescent and adult cancer: a population-based matched cohort study. Int J Cancer. 2011. p. 1225–36.
6.
Gerstl B, Sullivan E, Vallejo M, Koch J, Johnson M, Wand H, et al. Reproductive outcomes following treatment for a gynecological cancer diagnosis: a systematic review. J Cancer Surviv. 2019. p. 269–81.
7.
Gerstl B, Sullivan E, Koch J, Wand H, Ives A, Mitchell R, et al. Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis. Support Care Cancer. 2019. p. 4451–60.
8.
Sawka A, Lakra D, Lea J, Alshehri B, Tsang R, Brierley J, et al. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol (Oxf). 2008. p. 479–90.
9.
Signorello L, Cohen S, Bosetti C, Stovall M, Kasper C, Weathers R, et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst. 2006. p. 1453–61.
10.
Van Der Kooi A, Kelsey T, Van Den Heuvel-Eibrink M, Laven J, Wallace W, Anderson R. Perinatal complications in female survivors of cancer: a systematic review and meta-analysis. Eur J Cancer. 2019. p. 126–37.
11.
Cerovac A, Ljuca D, Nevacinovic E, Tulumovic A, Iljazovic E. Giving birth after fertility sparing treatment of embrional carcinoma Figo III C: case report and literature review. Med Arch. 2018. p. 371–3.
12.
Kashima K, Yahata T, Fujita K, Tanaka K. Outcomes of fertility sparing Surgery for women of reproductive age with FIGO stage IC epithelial ovarian cancer. Int J Gynaecol Obstet. 2013. p. 53–5.
13.
Sanctis D, Filippone V, Alfò F, Muni M, Cavalieri R, Pulsoni E, et al. Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2012. p. 755–61.
14.
Hirsch D, Levy S, Tsvetov G, Weinstein R, Lifshitz A, Singer J, et al. Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer. Thyroid. 2010. p. 1179–85.
15.
Budak A, Gulhan I, Aldemir O, Ileri A, Tekin E, Ozeren M. Lack of influence of pregnancy on the prognosis of survivors of thyroid cancer. Asian Pac J Cancer Prev. 2013. p. 6941–3.
16.
Blackburn B, Ganz P, Rowe K, Snyder J, Wan Y, Deshmukh V, et al. Reproductive and gynecological complication risks among thyroid cancer survivors. J Cancer Surviv. 2018. p. 702–11.
17.
Hartnett K, Ward K, Kramer M, Lash T, Mertens A, Spencer J, et al. The risk of preterm birth and growth restriction in pregnancy after cancer. Int J Cancer. 2017. p. 2187–96.
18.
Marković S, Bogdanović G, Cerovac A. Premature and preterm premature rupture of membranes in adolescent compared to adult pregnancy. Med Glas (Zenica). 2020. p. 136–40.
19.
Peccatori F, Azim H, Jr, Orecchia R, Hoekstra H, Pavlidis N, et al. ESMO Guidelines Working Group. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013. p. 160–70.
20.
Barton S, Najita J, Ginsburg E, Leisenring W, Stovall M, Weathers R, et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2013. p. 873–81.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
